Company news
Oxford Nanopore Technologies PLC news in 2022
Oxford Nanopore Technologies PLC's news releases, calls and decks from 2022, newest first.
Interim results for the period ended 30 June 2022
September 13, 2022
Sale and leaseback of headquarters building
July 11, 2022
Duncan Tatton-Brown appointed as Non-Exec Chair
June 30, 2022
ONT releases Remora: most comprehensive methylation
May 26, 2022
Oxford Nanopore announces tech updates
May 20, 2022
ONT opens user conference, rich science programme
May 19, 2022
ONT chosen for comprehensive human genome program
May 13, 2022
Genomics England expands Nanopore use in cancer
April 4, 2022
Agreement
April 1, 2022
ONT shows new high-accuracy, high-output chemistry
March 30, 2022
Nanopore sequencing profiles TB: FIND evaluation
March 24, 2022
Oxford Nanopore releases Short Fragment Mode
March 23, 2022
Preliminary Results and Guidance Update
March 22, 2022
Publication: Nanopore IDs >50 genetic diseases
March 8, 2022
Appointment of Senior Independent Director
January 24, 2022
Fastest human genome sequence uses Oxford Nanopore
January 13, 2022
Update to FY21 revenue guidance
January 7, 2022
Company to present at JP Morgan Healthcare conf
January 7, 2022
Decks in 2022
- H1 2022 Earnings Presentation
Earnings · 33 slides · Sep 13, 2022
- FY2021 Earnings Presentation
Earnings · 36 slides · Mar 22, 2022
- JP Morgan Healthcare Conference January 2022
Conference · 27 slides · January 2022